AIR: First stage commercialization of Oil Anti-Deposition Dispersant technology for spilled oil
AIR:溢油抗沉积分散剂技术第一阶段商业化
基本信息
- 批准号:1127846
- 负责人:
- 金额:$ 17.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:Standard Grant
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-08-01 至 2014-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Program Director's Recommendation Proposal #1127846 This project seeks to develop a class of bio-derived, biodegradable, oil dispersants which resist wetting and spreading on solid substrates such as plants and animals. The intellectual merit of this project is that more safe and effective dispersants are needed to help mitigate the impacts of oil spill disasters such as the Deepwater Horizon incident. The PIs have effectively used funds from the NSF RAPID program to identify a class of dispersants that are macromolecular aggregates of natural cellulose polymers and soy bean lecithin. A clear case is made that these compounds do not allow oil to foul bird feathers, and it is presumed that since they are natural in origin, they would be a safer alternative to the current petrochemically derived dispersants. The PIs have a strong record of expertise in this area, and are uniquely suited to this work. They clearly outline a detailed list of scientific and business-related questions that must be answered to push this product to the marketplace. The broader impact of discovering more effective and non-toxic oil dispersants is clear. The PIs have a strong record of incorporating others into their work, such as the local junior college students and instructors, some of whom are included as inventors of the disclosed technologies. There is a plan for student and workforce training that will span both the academic laboratory and associated industrial partner operations.
计划主任的建议提案#1127846该项目旨在开发一类生物衍生的、可生物降解的石油分散剂,其可抵抗在植物和动物等固体基质上的润湿和扩散。该项目的智力价值在于,需要更安全和有效的分散剂来帮助减轻深水地平线事件等漏油灾害的影响。PI有效地利用了NSF RAPID计划的资金来识别一类分散剂,这些分散剂是天然纤维素聚合物和大豆卵磷脂的大分子聚集体。一个明确的情况下,这些化合物不允许石油污染鸟类羽毛,据推测,因为它们是天然的,他们将是一个更安全的替代目前的石油化学衍生的分散剂。PI在这一领域拥有丰富的专业知识记录,并且非常适合这项工作。他们清楚地列出了一个详细的科学和商业相关问题的清单,这些问题必须得到回答,才能将这种产品推向市场。发现更有效和无毒的石油分散剂的广泛影响是显而易见的。PI在将其他人纳入其工作方面有着良好的记录,例如当地的大专学生和教师,其中一些人被列为所公开技术的发明者。有一个学生和劳动力培训计划,将跨越学术实验室和相关的工业合作伙伴业务。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert Lochhead其他文献
Robert Lochhead的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robert Lochhead', 18)}}的其他基金
PFI (RAPID): A Rapid Response Proposal for Mitigating the Deposition of Oil on Gulf Shores via Oil Anti-deposition Strategies
PFI(RAPID):通过石油反沉积策略减轻墨西哥湾沿岸石油沉积的快速响应提案
- 批准号:
1047662 - 财政年份:2010
- 资助金额:
$ 17.5万 - 项目类别:
Standard Grant
PFI: A Multinational Partnership to Incite Innovation via New Generation Tailored Polymers for Interfaces
PFI:跨国合作伙伴通过新一代接口定制聚合物激发创新
- 批准号:
0917730 - 财政年份:2009
- 资助金额:
$ 17.5万 - 项目类别:
Standard Grant
相似国自然基金
“Lignin-first”策略下镁碱催化原生木质素定向氧化为小分子有机酸的机制研究
- 批准号:21908075
- 批准年份:2019
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
基于First Principles的光催化降解PPCPs同步脱氮体系构建及其电子分配机制研究
- 批准号:51778175
- 批准年份:2017
- 资助金额:59.0 万元
- 项目类别:面上项目
相似海外基金
Characterization of the gene regulatory network governing the first cell fate decision in mammalian embryonic development
哺乳动物胚胎发育中第一个细胞命运决定的基因调控网络的表征
- 批准号:
10364821 - 财政年份:2022
- 资助金额:
$ 17.5万 - 项目类别:
Safety/Tolerability/Immunogenicity of first-in-human Aβ DNA vaccine, AV-1959D Phase 1 trials in early-stage AD subjects: based on IND18953 cleared by FDA.
首个人类 Aβ DNA 疫苗的安全性/耐受性/免疫原性,AV-1959D 在早期 AD 受试者中的 1 期试验:基于 FDA 批准的 IND18953。
- 批准号:
10340654 - 财政年份:2022
- 资助金额:
$ 17.5万 - 项目类别:
Characterization of the gene regulatory network governing the first cell fate decision in mammalian embryonic development
哺乳动物胚胎发育中第一个细胞命运决定的基因调控网络的表征
- 批准号:
10663784 - 财政年份:2022
- 资助金额:
$ 17.5万 - 项目类别:
Catchments as the first stage of treatment
集水区作为治疗的第一阶段
- 批准号:
2751386 - 财政年份:2022
- 资助金额:
$ 17.5万 - 项目类别:
Studentship
Safety/Tolerability/Immunogenicity of first-in-human Aβ DNA vaccine, AV-1959D Phase 1 trials in early-stage AD subjects: based on IND18953 cleared by FDA.
首个人类 Aβ DNA 疫苗的安全性/耐受性/免疫原性,AV-1959D 在早期 AD 受试者中的 1 期试验:基于 FDA 批准的 IND18953。
- 批准号:
10571883 - 财政年份:2022
- 资助金额:
$ 17.5万 - 项目类别:
Incremental Hemodialysis for Veterans in the First Year of Dialysis (IncHVets): A Pragmatic, Multi-Center, Randomized Controlled Trial
退伍军人透析第一年增量血液透析 (IncHVets):一项务实、多中心、随机对照试验
- 批准号:
10486289 - 财政年份:2022
- 资助金额:
$ 17.5万 - 项目类别:
Manganese Based MRI Contrast Agent - First In Human Clinical Trial
锰基 MRI 造影剂 - 首次进行人体临床试验
- 批准号:
10384872 - 财政年份:2021
- 资助金额:
$ 17.5万 - 项目类别:
Development of a stage-specific adaptation of a self-stigma intervention for people recovering from a first episode of psychosis
为从精神病首次发作中恢复的人开发针对阶段特定的自我污名干预措施
- 批准号:
10625525 - 财政年份:2021
- 资助金额:
$ 17.5万 - 项目类别:
Late-stage Preclinical Development and cGMP Production of a First-in-Class Cornea Cryopreservation Kit Based on FDA Feedback
根据 FDA 反馈,对一流的角膜冷冻保存试剂盒进行后期临床前开发和 cGMP 生产
- 批准号:
10326323 - 财政年份:2021
- 资助金额:
$ 17.5万 - 项目类别:
Manganese Based MRI Contrast Agent - First In Human Clinical Trial
锰基 MRI 造影剂 - 首次进行人体临床试验
- 批准号:
10495256 - 财政年份:2021
- 资助金额:
$ 17.5万 - 项目类别: